Skip to main content
. Author manuscript; available in PMC: 2014 Sep 2.
Published in final edited form as: Cancer Causes Control. 2014 Feb 1;25(4):479–489. doi: 10.1007/s10552-014-0350-1

Table 3.

Relative risks and 95 % CIs for smoking status and endometrial carcinoma risk by tumor characteristics

Tumor characteristicsa Smoking status
pheterogeneity
Never (n = 49,768)
Former (n = 41,824)
Current (n = 18,712)
Cases RR (95 % CI)b Cases RR (95 % CI)b Cases RR (95 % CI)b
Histology
 Type I 653 1 (ref) 490 0.92 (0.82, 1.03) 127 0.68 (0.56, 0.82) 0.15c
  Low-grade endometrioid 333 1 (ref) 244 0.90 (0.76, 1.06)   56 0.61 (0.46, 0.82) 0.34d
  High-grade endometrioid   42 1 (ref)   36 1.03 (0.66, 1.61)   12 1.04 (0.54, 2.00)
 Type II   63 1 (ref)   36 0.74 (0.49, 1.12)     8 0.41 (0.20, 0.87)
Stage 0.92e
 Localized 417 1 (ref) 288 0.85 (0.73, 0.98)   72 0.59 (0.46, 0.76)
 Regional/distant 111 1 (ref)   78 0.91 (0.68, 1.21)   17 0.53 (0.32, 0.89)
a

Associations were evaluated for subgroups defined by histology/grade and SEER summary stage using models to predict risk for one subgroup. Cases of other subgroups were censored at the time of diagnosis

b

Adjusted for race (white, non-white), age at menarche (≤12, 13–14, ≥15), BMI (normal, overweight, obese), parity (nulliparous, 1–2, ≥3), oral contraceptive use (never, ever), age at menopause (premenopausal,<45, 45–49, 50–54, ≥55), menopausal hormone use (never, current, former), diabetes (never, ever), physical activity (never/rarely, 1–3 times/month, 1–2 times/week, 3–4 times/week, ≥5 times/week). Unknown was set as a separate category within each factor

c

pheterogeneity is from logistic regression of case-only analysis comparing smoking status between Type I and Type II endometrial cancer cases

d

pheterogeneity is from logistic regression of case-only analysis comparing smoking status between low-grade endometrioid and high-grade endometrial cancer cases

e

pheterogeneity is from logistic regression of case-only analysis comparing smoking status between localized and regional/distant endometrial cancer cases